94268 ⎘
Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms Halogen atoms or nitro radicals
ACETYL-COA CARBOXYLASE MODULATORS
#2Formulated and/or Co-Formulated Liposome Compositions Containing IDO Antagonist Prodrugs Useful in the Treatment of Cancer and Methods Thereof
#3QUINOLINE DERIVATIVES
#4TLR7/8 ANTAGONISTS AND USES THEREOF
#5Montelukast berberine quaternary ammonium salt compound and double salt composition, and synthesis method therefor and use thereof
#6NOVEL INDOLEAMINE 2,3-DIOXYGENASE INHIBITORS, PROCESSES FOR THE PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME
#7HIGH PENETRATION COMPOSITIONS AND THEIR APPLICATIONS
#8Condoms lubricated with antiviral lubricious compositions containing lambda-carrageenan
#9QUINOLINE COMPOUNDS FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS DISEASE
#10INHIBITORS OF INTEGRATED STRESS RESPONSE PATHWAY
#11Quinoline derivatives
#123-N-CYCLOPROPYLMETHYL-2-FLUOROBENZAMIDE COMPOUND, PREPARATION METHOD THEREFOR AND USE THEREOF
#13SYNTHESIS OF DEUTERATED ALDEHYDES
#14Substituted Ureas and Methods of Making and Using Same
#15RADIOLIGANDS FOR IMAGING THE ID01 ENZYME
#16Substituted quinolinylcyclohexylpropanamide compounds and improved methods for their preparation
#17Covalent inhibitors of equine encephalitis virus
#18AMORPHOUS AND CRYSTALLINE FORMS OF IDO INHIBITORS
#19Heteroaromatic and Heterobicyclic Aromatic Derivatives for the Treatment of Ferroptosis-Related Disorders
#20SUBSTITUTED QUINOLINYLCYCLOHEXYLPROPANAMIDE COMPOUNDS AND IMPROVED METHODS FOR THEIR PREPARATION
#21Compound of 1-acetyl-6-fluoro-2,2,4-trimethyl-1,2,3,4-tetrahydroquinoline
#22Quinoline-based compounds and methods of inhibiting CDK8/19
#23ACETYL-COA CARBOXYLASE MODULATORS
#24Quinolines, polyquinolines, molecular segments of fullerenes and graphene nanoribbons, and graphene nanoribbons and methods of their synthesis
#25Toll-like receptor 8 (TLR8) specific antagonists and methods of making and uses thereof
#26Formulated and/or co-formulated liposome compositions containing IDO antagonist prodrugs useful in the treatment of cancer and methods thereof
#27Heterocyclic lipoxin analogs and uses thereof
#28TLR7/8 ANTAGONISTS AND USES THEREOF
#29TLR7/8 antagonists and uses thereof
#30Pyridinium, quinolinium, acridinium, pyrylium, chromenylium or xanthylizum reactive desorption and/or laser ablation ionization matrices and use thereof
#31Method for aromatic fluorination
#32Substituted ureas and methods of making and using same
#33Method for aromatic fluorination
#34Substituted quinolinylcyclohexylpropanamide compounds and improved methods for their preparation
#35Amorphous and crystalline forms of IDO inhibitors
#36Forms of (R)-N-(4-chlorophenyl)-2-(cis-4-(6-fluoroquinolin-4- yl)cyclohexyl)propanamide
#37Method for aromatic fluorination
#38RADIOLIGANDS FOR IMAGING THE IDO1 ENZYME
#39Cyclopropyl unsaturated quinoline compound used as leukotriene receptor antagonist and applications thereof
#40Method for aromatic fluorination
#41Substituted ureas and methods of making and using same
#42Inhibitors of integrated stress response pathway
#43Direct C—H amination and aza-annulation
#44Inhibitors of indoleamine 2,3-dioxygenase and methods of their use
#45Inhibitors of indoleamine 2,3-dioxygenase and methods of their use
#46Inhibitors of indoleamine 2,3-dioxygenase and methods of their use
#47Acetyl-CoA carboxylase modulators
#48Inhibitors of indoleamine 2,3-dioxygenase and methods of their use
#49Process for the preparation of polyfluoroalkylated quinolines
#50Quinoline derivatives and preparation thereof
#51Carboxy substituted (hetero) aromatic ring derivatives and preparation method and uses thereof
#52Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof
#53Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof
#54Fused quinoline compounds as PI3K/mTOR inhibitors
#55ORGANIC LIGHT EMITTING DEVICE WITH THERMALLY ACTIVATED DELAYED FLUORESCENT LIGHT EMITTING MATERIAL
#56Cyclopropyl unsaturated quinoline compound used as leukotriene receptor antagonist and applications thereof
#57TLR7/8 antagonists and uses thereof
#58Quinolines and process for the preparation thereof
#59Tetrahydroquinoline derivatives and their use as Epac inhibitors
#60Quinolines, polyquinolines, molecular segments of fullerenes and graphene nanoribbons, and graphene nanoribbons and methods of their synthesis
#61Safening 4-amino-3-chloro-6-(4-chloro-2-fluoro-3-methoxyphenyl)-5-fluoropyridine-2-carboxylic acid compositions in species and methods of use thereof
#62Fluorination method
#63Histone deacetylase inhibitors and compositions and methods of use thereof
#64Cytotoxic compounds which are inhibitors of the polymerisation of tubulin
#65Quinoline-based kinase inhibitors
#66Quinolines derivatives as novel anticancer agents
#67Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof
#68Process for preparation of herbicidal carboxylic acid salts
#69C-H fluorination of heterocycles with silver (II) fluoride
#70One-component reagent for the fluoroalkylation reaction
#71Reagents and methods for fluorinating a substrate
#72Acetyl CoA carboxylase modulators
#73S1P receptors modulators and their use thereof
#74Process for preparation of montelukast sodium
#75Compounds useful as immunomodulators
#76Tetrahydroquinoline derivatives and their use as Epac inhibitors
#77Histone deacetylase inhibitors and compositions and methods of use thereof
#78Graphene nanoribbons with controlled modifications
#79Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof
#80Sorbent comprising on its surface a cationic or protonizable aliphatic residue for the purification of organic molecules
#81Bis-quinaldine compound and a process for preparing the same
#82COMPOSITIONS AND METHODS FOR JAMM PROTEIN INHIBITION
#83Method for producing optically active tetrahydroquinolines
#84Histone deacetylase inhibitors and compositions and methods of use thereof
#85Cysteinyl leukotriene antagonists
#86Complex of amorphous tomoxiprole and cyclodextrin with fast dissolution rate and process for the preparation thereof
#87Substituted heterocyclic compounds as ion channel modulators
#88S1P receptors modulators and their use thereof
#89Quinolone compound and pharmaceutical composition
#90Androgen receptor modulator compounds and methods
#91Piperazinyl and piperidinyl ureas as modulators of fatty acid amide hydrolase
#92Heterocyclic compounds as imaging probes of tau pathology
#93Fluoroalkylation methods and reagents
#942-quinolinyl-acetic acid derivatives as HIV antiviral compounds
#95Inhibitors of human immunodeficiency virus replication
#96INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION
#97Pyrazoloquinolines
#98Crystalline pharmaceutical and methods of preparation and use thereof
#993,3-dimethyl tetrahydroquinoline derivatives
#100Quinolone compound and pharmaceutical composition
#101Nitrogen-containing heterocyclic compound and agricultural fungicide
#102PROCESS FOR THE PREPARATION OF MONTELUKAST AND SALTS THEREOF
#103Process for preparing Montelukast and salts thereof
#104SYNTHESIS OF OPTICALLY ACTIVE INTERMEDIATE FOR THE PREPARATION OF MONTELUKAST
#105Synthetic method for montelukast sodium intermediate
#106Purification of montelukast using simulated moving bed
#107Tetrahydroquinoline derivatives
#108QUINOLINES AS INHIBITORS OF FARNESYL PYROPHOSPHATE SYNTHASE
#109Hydroxamates as therapeutic agents
#110Heat Shock Protein 90 Inhibitors, Methods Of Preparing Same, And Methods For Their Use
#111NOVEL QUINOLINE ESTERS USEFUL FOR TREATING SKIN DISORDERS
#112S1P receptors modulators and their use thereof
#113Quinolone compound and pharmaceutical composition
#114High penetration compositions and their applications
#115Solid luminescent quinoline compounds
#1163,3-dimethyl tetrahydroquinoline derivatives
#117Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use
#118Method for preparing montelukast sodium salts
#119Compounds for the treatment of metabolic diseases
#120PROCESS FOR THE PREPARATION OF MONTELUKAST AND ITS SALTS
#121Nitrogen-containing aromatic derivatives
#122Process for preparing montelukast and salts thereof
#123Method for preparation of Montelukast acid in ionic liquid medium
#124PROCESS FOR THE PREPARATION OF MONTELUKAST AND ITS SALTS THEREOF
#125Method for producing unsaturated organic compound
#126PREPARATION OF MONTELUKAST AND ITS SALTS
#127SPECIFIC IMPURITIES OF MONTELUKAST
#128Hydrazone Compounds and Their Use
#129Inhibitors of human immunodeficiency virus replication
#130Hydroxamates as therapeutic agents
#131Metal-Catalyzed Carbon-Fluorine Bond Formation
#132Glucocorticoid Mimetics, Methods of Making Them, Pharmaceutical Compositions and Uses Thereof
#133Inhibitors of human immunodeficiency virus replication
#134Novel Crystalline Salts of Montelukast
#135MONTELUKAST BENZHYDRYL PIPERAZINE SALTS AND PROCESS FOR PREPARATION THEREOF
#136RENIN INHIBITORS
#137METHOD FOR ISOLATION AND PURIFICATION OF MONTELUKAST
#138Oxime ester compound and photopolymerization initiator containing the same
#139Malonic acid sulfonamide derivative and pharmaceutical use thereof
#140Process for preparing a leukotriene antagonist and an intermediate thereof
#141Nitrogen-containing aromatic derivatives
#142PROCESS AND INTERMEDIATE FOR THE PRODUCTION OF A TERTIARY ALCOHOL AS AN INTERMEDIATE IN THE SYNTHESIS OF MONTELUKAST
#143Compound having 11β-HSD1 inhibitory activity
#144METHOD FOR THE PREPARATION OF MONTELUKAST
#145Process for the Preparation of Montelukast
#1461H-QUINOLIN-4-ONE COMPOUNDS, WITH AFFINITY FOR THE GABA RECEPTOR, PROCESSES, USES AND COMPOSITIONS
#147Compounds and preparation for montelukast sodium
#148PROCESS FOR THE PREPARATION OF OPTICALLY ACTIVE ETHENYLPHENYL ALCOHOLS
#149SUBSTITUTED HETEROCYCLIC COMPOUNDS AS ION CHANNEL MODULATORS
#150Substituted pyridines as GPBAR1 agonists
#151PROCESS FOR MAKING MONTELUKAST AND INTERMEDIATES THEREFOR
#152Method of preparing montelukast and intermediates used therein
#153Carbamic acid compounds comprising a bicyclic heteroaryl group as HDAC inhibitors
#154Process for the preparation of montelukast, and intermediates therefor
#155PURIFICATION OF MONTELUKAST
#156PROCESS FOR THE PREPARATION OF SODIUM SALT OF 1-(((1(R)-(3-(2-(7-CHLORO-2-QUINOLINYL)-ETHENYL)PHENYL)-3-(2-(1-HYDROXY-1-METHYLETHYL)PHENYL)PROPYL)SULFANYL)METHYL)CYCLOPROPANEACETIC ACID
#157PROCESS FOR PREPARATION OF SOLID MONTELUKAST
#158Process for pure montelukast sodium through pure intermediates as well as amine salts
#159Process for the purification of Montelukast
#160Process for the Preparation of E-3-[2-(7-Chloro-2-Quinolinyl)Ethenyl]Benzaldehyde
#161Piperazinyl and piperidinyl ureas as modulators of fatty acid amide hydrolase
#162Process for the Preparation of Leukotriene Receptor Antagonist (Montelukast Sodium)
#163PROCESS FOR THE MANUFACTURE OF MONTELUKAST SODIUM
#164Quinolinylmethyl Compounds
#165PROCESS FOR MAKING MONTELUKAST INTERMEDIATES
#166Diphenylmethane Derivatives as Inhibitors of Leukotriene Biosynthesis
#167BCRP/ABCG2 inhibitor
#168Purification process of Montelukast and its amine salts
#169Hydroxamates as therapeutic agents
#170PROCESS FOR THE MANUFACTURE OF MONTELUKAST SODIUM
#171Process for the preparation of Montelukast and its pharmaceutically acceptable salts
#172Dye-sensitized photoelectric conversion device
#173Quinolines and their therapeutic use
#174Process for the Preparation of Montelukast and its Salts
#175CRYSTALLINE SALT OF MONTELUKAST
#176Process for preparing a leukotriene antagonist
#177PROCESS FOR MAKING MONTELUKAST AND INTERMEDIATES THEREFOR
#178Quinoline Compounds
#179Method of making and administering quinoline derivatives as anti-cancer agents
#180SUBSTITUTED QUINOLINE DERIVATIVES
#181Novel Salt of Montelukast
#182DEUTERIUM-ENRICHED MONTELUKAST
#183Process for the Preparation of a Leukotriene Antagonist and Intermediates Thereof
#184Methyl 2-[(3S)-[3-[2E)-(7-chloro quinolin-2-yl) ethenyl] phenyl]-3-halopropyl] benzoates
#185Hydroxamates as therapeutic agents
#186Hydroxamates as therapeutic agents
#187Inhibitors of human immunodeficiency virus replication
#188Preparation of Montelukast
#189Process For the Preparation of a Leukotriene Antagonist
#190Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
#191PROCESS FOR OBTAINING MONTELUKAST
#192PROCESS FOR PREPARING MONTELUKAST SODIUM CONTAINING CONTROLLED LEVELS OF IMPURITIES
#193Process for the Preparation of Novel Amorphous Montelukast Sodium
#194CARBOXYLIC ACID AMIDES, THE PREPARATION THEREOF, AND THEIR USE AS PHARMACEUTICAL COMPOSITIONS
#195Compounds and preparation for montelukast sodium
#196Hydroxamates as therapeutic agents
#197Mycobacterial inhibitors
#198Niacin Receptor Agonists, Compositions Containing Such Compounds and Methods of Treatment
#199NOVEL HYDROXAMATES AS THERAPEUTIC AGENTS
#200Method For Preparation Of A Fluoroaromatic Compound From An Aminoaromatic Compound
#201Mono-nitration of aromatic compounds via nitrate salts
#202INTRACELLULAR RECEPTOR MODULATOR COMPOUNDS AND METHODS
#203Androgen receptor modulator compounds and methods
#204Montelukast amantadine salt
#205Solid Forms of Montelukast Acid
#206Novel polymorphs of montelukast ammonium salts and processes for preparation therefor
#207Process for preparing montelukast and salts thereof
#208Process for preparing 1-(mercaptomethyl)cyclopropaneacetic acid, a useful intermediate in the preparation of montelukast and salts thereof
#209Drying methods of montelukast sodium by azeotropic removal of the solvent
#210Process for making montelukast and intermediates therefor
#211Process for making montelukast and intermediates therefor
#212Process for making montelukast and intermediates therefor
#213Process for the synthesis of quinoline derivatives
#214Method for the preparation of montelukast acid and sodium salt thereof in amorphous form
#215Purification of montelukast
#216Bioisosteres of actinonin
#217Substituted indoles and a process for preparing substituted indoles
#218PREPARATION OF BISQUINOLINE COMPOUNDS
#219Nitrogen-containing aromatic derivatives
#220Process for preparing montelukast and precursors thereof
#221Process for the preparation of Montelukast
#222Polymorphic form of montelukast sodium
#223Piperazinyl and piperidinyl ureas as modulators of fatty acid amide hydrolase
#224Nitrogen-containing aromatic derivatives
#225Fused heterocyclic compounds as peptidase inhibitors
#226Piperazine derivatives and their use as anti-inflammatory agents
#227Androgen receptor agonists
#228Phosphodiesterase inhibitor
#229Quinolines as allosteric enhancers of the GABAreceptors
#230Carbamic acid compounds comprising a bicyclic heteroaryl group as HDAC inhibitors
#231Substituted quinoline and quinazoline inhibitors of quinone reductase 2
#232Compounds for the treatment of inflammatory disorders
#233Compounds with anti-bacterial activity
#234Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
#235Heterocyclic anti-epileptogenic agents and methods of use thereof
#236Process for preparation of montelukast and its salts
#237Process for preparation of amorphous form of a drug
#238Substituted quinoline derivatives
#239Processes for preparing montelukast sodium
#240Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds
#241Process for making montelukast and intermediates therefor
#242Process for making montelukast and intermediates therefor
#243Process for the preparation of [R-(E)-1-[[[1-[3-[2-[7-chloro-2-quinolinyl]ethenyl]phenyl]-3-[2-(1-hydroxy-1-methylethyl)phenyl]propyl]thio]methyl]cyclopropaneacetic acid (Montelukast) and its pharmaceutically acceptable salts
#244Metabotropic glutamate receptor antagonists
#245Hydroxamates as therapeutic agents
#246Montelukast sodium polymorphs
#247Montelukast free acid polymorphs
#248Process for preparing 3-fluoroquinolines
#249Process for preparation of montelukast and its salts
#250Solid-state montelukast